(LifeSiteNews) – 51 percent of Americans support distributing abortion pills by mail according to a new poll, contradicting another recent poll indicating the opposite and forecasting the difficult road ahead for reshaping U.S. public opinion on life.
The Center Square’s latest Voters Voice Poll, published September 3, reported that a combined 51 percent of respondents either “somewhat” or “strongly” favor “allowing abortion pills to be prescribed online and mailed directly to patients,” compared to just 37 percent who are “somewhat” or “strongly” opposed (an additional 12 percent was unsure).
At the same time, 48 percent of respondents also agreed that doing so “raises safety and accountability concerns because it may be harder to verify who is receiving or using the medication,” compared to 39 percent whose top takeaway was that it “protects access to abortion for women who may not be able to visit a clinic in person.”
The discrepancy may indicate that how the issue is presented to respondents significantly influences their responses. Last month, a Zogby poll commissioned by Concerned Women for America found that 67.6 percent “definitely or probably believe that the FDA should again require an in-person doctor’s visit before dispensing the abortion drug.”
Both polls underscore the importance of making the case that mail-order pills, which have become the abortion lobby’s most potent tool for circumventing these laws and preserving abortion without Roe v. Wade, are even more dangerous to women than pills “properly” administered.
An April 2025 analysis by the Ethics and Public Policy Center (EPPC) concluded that almost 11 percent of women suffer sepsis, infection, hemorrhaging, or other major conditions after taking mifepristone, according to insurance data, joining similar findings by the Restoration of America Foundation to form a “growing body of evidence indicating that the health risks associated with mifepristone abortions are severe, widespread, and significantly underreported.” Those risks are only magnified, pro-lifers warn, when the pills are allowed to be taken in complete privacy, without medical supervision or close access to emergency services, for no other reason than to evade state pro-life laws.
Pro-lifers are currently waiting to see whether a long-awaited data review by the U.S. Food and Drug Administration will lead to the Trump administration restoring the in-person dispensing requirement that has enabled the abortion-by-mail scheme.
Multiple states are suing to force a restoration of the requirement; one suit has been delayed until after the November midterm elections, while oral arguments in another are slated to begin tomorrow.